Published in Dig Dis Sci on November 01, 2012
Lubiprostone in constipation: clinical evidence and place in therapy. Ther Adv Chronic Dis (2015) 0.78
Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents. Front Pharmacol (2017) 0.75
CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit Rev Biochem Mol Biol (2008) 5.03
A chloride channel widely expressed in epithelial and non-epithelial cells. Nature (1992) 3.60
Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest (2009) 2.37
SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am J Physiol Cell Physiol (2004) 2.33
A frame-shift mutation in the cystic fibrosis gene. Nature (1990) 2.23
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther (2008) 2.06
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol (2006) 1.94
Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2012) 1.83
Lubiprostone targets prostanoid signaling and promotes ion transporter trafficking, mucus exocytosis, and contractility. Dig Dis Sci (2012) 1.61
Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. Gastroenterology (2009) 1.59
Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon. Br J Pharmacol (2008) 1.54
CLC chloride channels and transporters. Curr Opin Neurobiol (2005) 1.53
Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2008) 1.50
Distribution of ClC-2 chloride channel in rat and human epithelial tissues. Am J Physiol Cell Physiol (2002) 1.44
A synthetic prostone activates apical chloride channels in A6 epithelial cells. Am J Physiol Gastrointest Liver Physiol (2008) 1.35
Basolateral localization of native ClC-2 chloride channels in absorptive intestinal epithelial cells and basolateral sorting encoded by a CBS-2 domain di-leucine motif. J Cell Sci (2005) 1.33
Analysis of ClC-2 channels as an alternative pathway for chloride conduction in cystic fibrosis airway cells. Proc Natl Acad Sci U S A (1998) 1.19
Basolateral ClC-2 chloride channels in surface colon epithelium: regulation by a direct effect of intracellular chloride. Gastroenterology (2004) 1.15
Stimulation of mucosal secretion by lubiprostone (SPI-0211) in guinea pig small intestine and colon. Am J Physiol Gastrointest Liver Physiol (2009) 1.12
Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation. Dig Dis Sci (2011) 1.06
ClC and CFTR chloride channel gating. Annu Rev Physiol (1998) 1.05
Lubiprostone stimulates duodenal bicarbonate secretion in rats. Dig Dis Sci (2009) 1.03
Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84. Dig Dis Sci (2010) 1.00
Lubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestine. Dig Dis Sci (2010) 1.00
Additional disruption of the ClC-2 Cl(-) channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models. J Biol Chem (2004) 0.99
ClC-2 in guinea pig colon: mRNA, immunolabeling, and functional evidence for surface epithelium localization. Am J Physiol Gastrointest Liver Physiol (2002) 0.93
Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype. BMC Gastroenterol (2010) 0.93
Use of the chloride channel activator lubiprostone for constipation in adults with cystic fibrosis: a case series. Ann Pharmacother (2010) 0.90
Lubiprostone targets prostanoid EP₄ receptors in ovine airways. Br J Pharmacol (2011) 0.89
Severe defects in absorptive ion transport in distal colons of mice that lack ClC-2 channels. Gastroenterology (2011) 0.87
Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome. Expert Opin Drug Saf (2012) 0.85
Lubiprostone for constipation in adults with cystic fibrosis: a pilot study. Ann Pharmacother (2011) 0.79
Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile. Gastroenterology (2007) 1.73
Membrane transport proteins: not just for transport anymore. Am J Physiol Renal Physiol (2006) 1.44
Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Dig Dis Sci (2010) 1.39
Duodenal brush border intestinal alkaline phosphatase activity affects bicarbonate secretion in rats. Am J Physiol Gastrointest Liver Physiol (2007) 1.24
Intestinal alkaline phosphatase regulates protective surface microclimate pH in rat duodenum. J Physiol (2009) 1.24
Epithelial carbonic anhydrases facilitate PCO2 and pH regulation in rat duodenal mucosa. J Physiol (2006) 1.17
Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats. J Pharmacol Exp Ther (2011) 1.12
Luminal L-glutamate enhances duodenal mucosal defense mechanisms via multiple glutamate receptors in rats. Am J Physiol Gastrointest Liver Physiol (2009) 1.11
A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats. Am J Physiol Gastrointest Liver Physiol (2005) 1.08
Lubiprostone stimulates duodenal bicarbonate secretion in rats. Dig Dis Sci (2009) 1.03
Carbonic anhydrases and mucosal vanilloid receptors help mediate the hyperemic response to luminal CO2 in rat duodenum. Gastroenterology (2006) 1.03
Luminal chemosensing and upper gastrointestinal mucosal defenses. Am J Clin Nutr (2009) 1.02
Lafutidine, a protective H₂ receptor antagonist, enhances mucosal defense in rat esophagus. Dig Dis Sci (2010) 1.00
NHE3 inhibition activates duodenal bicarbonate secretion in the rat. Am J Physiol Gastrointest Liver Physiol (2003) 0.97
Compound Danshen injection improves endotoxin-induced microcirculatory disturbance in rat mesentery. World J Gastroenterol (2007) 0.97
Dipeptidyl peptidase IV inhibition potentiates amino acid- and bile acid-induced bicarbonate secretion in rat duodenum. Am J Physiol Gastrointest Liver Physiol (2012) 0.96
Gastroduodenal mucosal defense. Curr Opin Gastroenterol (2010) 0.94
Cystic fibrosis gene mutation reduces epithelial cell acidification and injury in acid-perfused mouse duodenum. Gastroenterology (2004) 0.94
Expression of Musashi-1 in the rat stomach and changes during mucosal injury and restitution. FEBS Lett (2005) 0.94
Gastric cancer mimicking a submucosal tumor diagnosed by laparoscopic excision biopsy. J Laparoendosc Adv Surg Tech A (2005) 0.93
Gastroduodenal mucosal defense. Curr Opin Gastroenterol (2009) 0.90
Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation. Jpn J Clin Oncol (2003) 0.90
Evaluation of a pharmacist-managed hepatitis C care clinic. Am J Health Syst Pharm (2007) 0.89
Dipeptidyl peptidase IV inhibition prevents the formation and promotes the healing of indomethacin-induced intestinal ulcers in rats. Dig Dis Sci (2013) 0.89
Gastrointestinal defense mechanisms. Curr Opin Gastroenterol (2011) 0.89
Mechanism of augmented duodenal HCO(3)(-) secretion after elevation of luminal CO(2). Am J Physiol Gastrointest Liver Physiol (2004) 0.87
CFTR inhibition augments NHE3 activity during luminal high CO2 exposure in rat duodenal mucosa. Am J Physiol Gastrointest Liver Physiol (2008) 0.87
Duodenal chemosensing and mucosal defenses. Digestion (2011) 0.87
Short-chain fatty acid sensing in rat duodenum. J Physiol (2015) 0.86
Complete response of a highly advanced gastric carcinoma to preoperative chemoradiotherapy with S-1 and low-dose cisplatin. Gastric Cancer (2003) 0.86
Acid-sensing pathways in rat gastrointestinal mucosa. J Gastroenterol (2002) 0.86
Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity. Dig Dis Sci (2013) 0.85
Significant role of ceramide pathway in experimental gastric ulcer formation in rats. J Pharmacol Exp Ther (2003) 0.84
Duodenal carbonic anhydrase: mucosal protection, luminal chemosensing, and gastric acid disposal. Keio J Med (2006) 0.83
Gastroduodenal defense. Curr Opin Gastroenterol (2007) 0.83
[A case of advanced gastric cancer with lymphangitis carcinomatosa after operation of Krukenberg tumor treated by TS-1 plus CPT-11 as third-line chemotherapy]. Gan To Kagaku Ryoho (2005) 0.83
Gastroduodenal mucosal defense: role of endogenous mediators. Curr Opin Gastroenterol (2004) 0.82
Low-dose PGE2 mimics the duodenal secretory response to luminal acid in mice. Am J Physiol Gastrointest Liver Physiol (2004) 0.82
Gastroduodenal mucosal defense. Curr Opin Gastroenterol (2008) 0.82
The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice. J Gastroenterol Hepatol (2015) 0.82
Role of lysophosphatidylcholine in brush-border intestinal alkaline phosphatase release and restoration. Am J Physiol Gastrointest Liver Physiol (2009) 0.81
Unusual complication: superior mesenteric artery syndrome and closed loop gastroduodenal obstruction after adjustable gastric banding. Surg Obes Relat Dis (2010) 0.81
Endogenous luminal surface adenosine signaling regulates duodenal bicarbonate secretion in rats. J Pharmacol Exp Ther (2010) 0.80
Duodenal chemosensing: master control for epigastric sensation? J Gastroenterol Hepatol (2011) 0.80
Mechanisms of intragastric pH sensing. Curr Gastroenterol Rep (2010) 0.79
Gastroduodenal mucosal defense. Curr Opin Gastroenterol (2014) 0.79
Cyclooxygenase (COX)-1 and COX-2 both play an important role in the protection of the duodenal mucosa in cats. J Pharmacol Exp Ther (2012) 0.79
Duodenal luminal chemosensing; acid, ATP, and nutrients. Curr Pharm Des (2014) 0.79
Attenuating effect of Myakuryu on mesenteric microcirculatory disorders induced by ischemia and reperfusion. Clin Hemorheol Microcirc (2006) 0.78
Gastroduodenal mucosal defense mechanisms. Curr Opin Gastroenterol (2015) 0.78
Luminal acid elicits a protective duodenal mucosal response. Keio J Med (2002) 0.77
Gastroduodenal mucosal defense. Curr Opin Gastroenterol (2006) 0.76
Gastroduodenal mucosal defense. Curr Opin Gastroenterol (2013) 0.76
Peripheral corticotropin-releasing factor receptor type 2 activation increases colonic blood flow through nitric oxide pathway in rats. Dig Dis Sci (2015) 0.76
Gastroduodenal mucosal defense: an integrated protective response. Curr Opin Gastroenterol (2003) 0.76
CRC screening, past, present, and future: a tribute to Emmet Keeffe. Dig Dis Sci (2015) 0.76
A novel phosphorus repletion strategy in a patient with duodenal perforation. Nutr Clin Pract (2014) 0.76
Role of gastric mast cells in the regulation of central TRH analog-induced hyperemia in rats. Peptides (2005) 0.76
Gastroduodenal mucosal defense: an integrated protective response. Curr Opin Gastroenterol (2002) 0.75
Compounded bioidentical hormone therapy: time for a reality check? Menopause (2015) 0.75
From bedside to bench: reverse engineering medical progress. Dig Dis Sci (2012) 0.75
Wireless telemetry and cystic fibrosis: just the pHacts. Dig Dis Sci (2013) 0.75
Prostaglandin pathways in duodenal chemosensing. J Gastroenterol Hepatol (2014) 0.75
Oesophageal sensation in response to high PCO(2) and acidic solutions in nonerosive reflux disease. Eur J Clin Invest (2011) 0.75
Luminal chemosensing in the gastroduodenal mucosa. Curr Opin Gastroenterol (2017) 0.75
Gastroduodenal mucosal defense. Curr Opin Gastroenterol (2012) 0.75
Introduction to the "GRG Scholars Invited Reviews". Dig Dis Sci (2013) 0.75
Gastrointestinal defense mechanisms. Curr Opin Gastroenterol (2016) 0.75
Covering digestive diseases and sciences: how to judge a journal by its cover. Dig Dis Sci (2013) 0.75
Personal reminiscences about Morton Grossman and the founding of the Center for Ulcer Research and Education (CURE). Am J Physiol Gastrointest Liver Physiol (2008) 0.75
Bringing the Bacon home. Dig Dis Sci (2013) 0.75
Role of protein kinases on acid-induced duodenal bicarbonate secretion in rats. Pharmacology (2003) 0.75